Kenneth Beagley

Professor Kenneth Beagley is a leading immunologist at Queensland University of Technology (QUT), affiliated with the Faculty of Health and School of Biomedical Sciences. His research focuses on vaccine development for chlamydial infections, mucosal immunization methods, and understanding chronic chlamydial infection impacts on immunity. He holds a PhD from the University of Otago and has published extensively in immunology and infectious disease research.

His work includes developing DNA vaccines targeting conserved chlamydial antigens, investigating needle-free immunization techniques (e.g., transcutaneous, intranasal), and studying chlamydial effects on immune cells like dendritic cells and macrophages. Notable collaborations include projects with Dr. Tim Dargaville on vaccine stability and studies on koala chlamydial pathology with Dr. Courtney Hulse and Dr. Cinzia Palmieri.

Recent publications (2022–2024) highlight advancements in chlamydia vaccine design, immunopathology mechanisms, and koala conservation through microbiome analysis. His research bridges basic immunology with translational medicine, aiming to combat sexually transmitted diseases and wildlife health crises.

Beagley’s contributions include over 130 peer-reviewed articles, with a focus on interdisciplinary approaches to infectious disease control. He is actively involved in mentoring, though specific student names are not listed in available texts.